EOF abolishes the circulation of injectable drugs.

The decision to recall, EOF said in a statement, was made because “after receiving information about the possibility of detecting stainless steel particles in a sterile solution that come from a component that is part of the product’s production line.”

These are batches of the following two drugs:

• CELESTONE CHRONODOSE INJ.SU.RET (3+3)MG/1 ML BOTTLE
• PROPIOCHRON ENG.SUSP (5+2) mg/1ml

Details of recalled drugs, lot number and expiration date for each:

The active substance of both drugs is betamethasone, which, according to its activity, belongs to potent local corticosteroids and has an anti-inflammatory effect.

They are indicated in the treatment of severe and moderate diseases, in acute and chronic self-limiting diseases, amenable to systemic treatment with corticosteroids.

The EOF decision was taken as a precautionary measure in the context of protecting public health, the report says.

Tables with batches of recalled drugs: